{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:12:50Z","timestamp":1783681970746,"version":"3.55.0"},"reference-count":30,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Rare Tumors"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    Second malignant neoplasms (SMNs) are rare but serious late effects in childhood acute lymphoblastic leukemia (ALL) survivors. Mature peripheral T-cell lymphomas involving both the breast and ovary are exceedingly rare, and their relationship with germline predisposition variants remains poorly understood. We report a 17-year-old female, previously treated for high-risk B-cell ALL and in sustained remission, who developed bilateral breast and ovarian masses in 2024. Histopathology and immunohistochemistry confirmed a mature T-cell lymphoma (CD7\n                    <jats:sup>+<\/jats:sup>\n                    , CD99\n                    <jats:sup>+<\/jats:sup>\n                    , weak CD5\/CD3, Ki-67 &gt;90%, TdT\n                    <jats:sup>\u2013<\/jats:sup>\n                    ). Whole-exome sequencing revealed a germline pathogenic\n                    <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                    variant (c.1910-2A&gt;T) along with additional likely pathogenic variants (\n                    <jats:italic toggle=\"yes\">CUX1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">MED12L<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">POLR3B<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                    ). The disease progressed rapidly despite CHOP chemotherapy, and the patient died shortly after diagnosis. This report describes an exceptionally rare SMN of peripheral T-cell lymphoma with breast and ovarian involvement in a pediatric leukemia survivor. The coexistence of a germline\n                    <jats:italic toggle=\"yes\">BRCA2<\/jats:italic>\n                    mutation and additional genomic alterations suggests a multigenic predisposition hypothesis. Early incorporation of next-generation sequencing may uncover molecular vulnerabilities and inform alternative therapeutic strategies in refractory hematologic malignancies.\n                  <\/jats:p>","DOI":"10.1177\/20363613261443114","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:33:21Z","timestamp":1783488801000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["T-cell lymphoma of the breast and ovary presenting as a second malignant neoplasm in a pediatric leukemia survivor: A case report and literature review"],"prefix":"10.1177","volume":"18","author":[{"given":"Oscar","family":"Alvarez-Palacios","sequence":"first","affiliation":[{"name":"Instituto Estatal de Cancerolog\u00eda \u201cDr. Arturo Beltr\u00e1n Ortega\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ojeda-Campos","sequence":"additional","affiliation":[{"name":"Instituto Estatal de Cancerolog\u00eda \u201cDr. Arturo Beltr\u00e1n Ortega\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico"},{"name":"Instituto Nacional de Pediatr\u00eda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Ernesto","family":"D\u00edaz-Juarez","sequence":"additional","affiliation":[{"name":"Instituto Estatal de Cancerolog\u00eda \u201cDr. Arturo Beltr\u00e1n Ortega\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Figueroa-Torres","sequence":"additional","affiliation":[{"name":"Instituto Estatal de Cancerolog\u00eda \u201cDr. Arturo Beltr\u00e1n Ortega\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-4729","authenticated-orcid":false,"given":"Roc\u00edo","family":"Ju\u00e1rez-Vel\u00e1zquez","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Pediatr\u00eda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulises","family":"Ju\u00e1rez-Figueroa","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Pediatr\u00eda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Johans","family":"Gallardo-Navarro","sequence":"additional","affiliation":[{"name":"Instituto Estatal de Cancerolog\u00eda \u201cDr. Arturo Beltr\u00e1n Ortega\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fabian","family":"Segundo-Galvez","sequence":"additional","affiliation":[{"name":"Instituto Estatal de Cancerolog\u00eda \u201cDr. Arturo Beltr\u00e1n Ortega\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2823-1743","authenticated-orcid":false,"given":"Azucena","family":"Ocampo-B\u00e1rcenas","sequence":"additional","affiliation":[{"name":"Instituto Estatal de Cancerolog\u00eda \u201cDr. Arturo Beltr\u00e1n Ortega\u201d"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15777"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22806"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes10010037"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710163"},{"issue":"12","key":"e_1_3_6_6_2","first-page":"130","article-title":"Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors","volume":"6","author":"Yavvari S","year":"2019","unstructured":"Yavvari S, Makena Y, Sukhavasi S, et al. Large Population Analysis of Secondary Cancers in Pediatric Leukemia Survivors. Children (Basel) 2019; 6(12): 130. https:\/\/doi.org\/10.3390\/children6120130","journal-title":"Children (Basel)"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.0500"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3181"},{"issue":"1","key":"e_1_3_6_9_2","first-page":"351","article-title":"Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies","volume":"109","author":"Stubbins RJ","year":"2024","unstructured":"Stubbins RJ, Asom AS, Wang P, et al. Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies. Haematologica 2024; 109(1): 351\u2013356. https:\/\/doi.org\/10.3324\/haematol.2022.281580","journal-title":"Haematologica"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200602001-00059"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/35049074"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199302000-00007"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-120535"},{"issue":"4","key":"e_1_3_6_14_2","first-page":"e57399","article-title":"T-Cell Acute Lymphoblastic Leukemia\/Lymphoma (T-ALL) With Negative Screening Immaturity Markers and Gamma-Delta Receptor Expression","volume":"16","author":"Faraz M","year":"2024","unstructured":"Faraz M, Parmigiani A, Monkash N, et al. T-Cell Acute Lymphoblastic Leukemia\/Lymphoma (T-ALL) With Negative Screening Immaturity Markers and Gamma-Delta Receptor Expression. Cureus 2024; 16(4): e57399. https:\/\/doi.org\/10.7759\/cureus.57399","journal-title":"Cureus"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-224570"},{"issue":"6","key":"e_1_3_6_16_2","first-page":"514","article-title":"Analysis of surface antigen profile, TdT expression, and T cell receptor gene rearrangement for maturational staging of leukemic T cells: a pediatric oncology group study","volume":"1","author":"Morabito F","year":"1987","unstructured":"Morabito F, Prasthofer EF, Pullen DJ, et al. Analysis of surface antigen profile, TdT expression, and T cell receptor gene rearrangement for maturational staging of leukemic T cells: a pediatric oncology group study. Leukemia 1987; 1(6): 514\u2013517.","journal-title":"Leukemia"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-016-0277-4"},{"issue":"9","key":"e_1_3_6_18_2","first-page":"1523","article-title":"Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia","volume":"9","author":"van Wering ER","year":"1995","unstructured":"van Wering ER, Beishuizen A, Roeffen ET, et al. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia 1995; 9(9): 1523\u20131533.","journal-title":"Leukemia"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/406796"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102310"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-152"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001771"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-426965"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009195"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2664"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.01.007"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13072-025-00610-9"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2024.103714"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.696438"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/applbiosci2030029"}],"container-title":["Rare Tumors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20363613261443114","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20363613261443114","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20363613261443114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:16:53Z","timestamp":1783678613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20363613261443114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["10.1177\/20363613261443114"],"URL":"https:\/\/doi.org\/10.1177\/20363613261443114","relation":{},"ISSN":["2036-3613","2036-3613"],"issn-type":[{"value":"2036-3613","type":"print"},{"value":"2036-3613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"20363613261443114"}}